Evaluating acupuncture as a therapeutic intervention for post-COVID-19 olfactory dysfunction: a systematic review and pilot study

Abstract

Objective: Olfactory dysfunction (OD) is a common and persistent symptom of coronavirus disease 2019 (COVID-19) for which effective treatments remain limited. Acupuncture, widely used in Chinese medicine for olfactory disorders has uncertain efficacy in post-COVID-19 OD. Therefore, in this study, we aimed to explore the feasibility and preliminary efficacy of acupuncture in patients with post-COVID-19 OD. Methods: This study was a dual-phased study. Phase I involved a systematic review conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, encompassing eight databases. Phase II consisted of a pilot randomized controlled trial (RCT) enrolling 25 patients with moderate to severe post-COVID-19 OD. Participants were randomly assigned to receive either real (group A) or sham (group B) acupuncture. The intervention included eight sessions over 4 weeks, with assessments at baseline, post-cycle 1, 2-week washout, post-cycle-2 treatment, and 2-week follow-up. The primary outcome was the change in scores on the 12-item Assessment of Self-Reported Olfactory Functioning and Quality of Life (ASOF). Secondary outcomes included the short version of the Questionnaire of Olfactory Disorders-Negative Statements (sQOD-NS) and the traditional Chinese version of the University of Pennsylvania Smell Identification Test (UPSIT-TC). Results: The systematic review identified 22 studies (15 case reports, seven RCTs) suggesting that acupuncture may positively influence olfactory function. In the pilot RCT, no significant baseline differences were observed between groups. Group A showed steady improvement across all ASOF domains during Cycle 1 (SOC, mean = 5.86; SRP, mean = 3.26; ORQ, mean = 3.98), with slight declines during cycle 2 and 2-week follow-up, though scores remained above baseline. Post-cycle 1, group A showed higher mean SOC and ORQ scores compared with group B (7.00 vs. 4.67; 3.98 vs. 3.39). Improvements in secondary outcomes were also more pronounced in group A, whereas group B showed minimal changes. Conclusion: Acupuncture appears to be a safe and potentially effective treatment for post-COVID-19 OD, warranting validation through larger clinical trials.

Keywords

Acupuncture / COVID-19 / Olfactory dysfunction / Pilot study / Systematic literature review

References

[1] Wu D, Wang VY, Chen Y—H, et al. The prevalence of olfactory and gustatory dysfunction in COVID—19—a systematic review. Auris Nasus Larynx 2022; 49: 165-175.

[2] Mutiawati E, Fahriani M, Mamada SS, et al. Anosmia and dysgeusia in SARS—CoV—2 infection: incidence and effects on COVID—19 severity and mortality, and the possible pathobiology mechanisms—a systematic review and meta—analysis. F1000Res 2021; 10: 40.

[3] Garg S, Kim L, Whitaker M, et al. Hospitalization rates and characteristics of patients hospitalized with laboratory—confirmed coronavirus disease 2019—COVID—NET, 14 States, March 1—30, 2020. MMWR Morb Mortal Wkly Rep 2020; 69: 458-464.

[4] Cao LJ, Wu XL, Zhang CY, et al. Short—term post—COVID—19 symptoms in Chinese patients from 31 provinces: a cross—sectional study. Acupunct Herb Med 2025; 5(3): 291-300.

[5] Husain Q, Kokinakos K, Kuo Y—H, et al. Characteristics of COVID—19 smell and taste dysfunction in hospitalized patients. Am J Otolaryngol 2021; 42: 103068.

[6] Qiu C, Cui C, Hautefort C, et al. Olfactory and gustatory dysfunction as an early identifier of COVID—19 in adults and children: an international multicenter study. Otolaryngol Head Neck Surg 2020; 163: 714-721.

[7] Peter KM Ku. Revisiting smell and taste dysfunctions during COVID—19 pandemic in Hong Kong. AJBSR 2020; 9(3): 230-235.

[8] Chin WY. Are loss of smell or taste being considered important symptoms for COVID—19 patients in Hong Kong?. Hong Kong Pract 2021; 43(2): 35-37.

[9] Natoli S, Oliveira V, Calabresi P, et al. Does SARS—Cov—2 invade the brain? Translational lessons from animal models. Eur J Neurol 2020; 27: 1764-1773.

[10] Gu J, Gong E, Zhang B, et al. Multiple organ infection and the pathogenesis of SARS. J Exp Med 2005; 202: 415-424.

[11] Gu J, Korteweg C. Pathology and pathogenesis of severe acute respiratory syndrome. Am J Pathol 2007; 170: 1136-1147.

[12] Kirschenbaum D, Imbach LL, Ulrich S, et al. Inflammatory olfactory neuropathy in two patients with COVID—19. Lancet 2020; 396: 166.

[13] de Melo GD, Lazarini F, Levallois S, et al. COVID—19—related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci Transl Med 2021; 13: eabf8396.

[14] Klingenstein M, Klingenstein S, Neckel PH, et al. Evidence of SARS—CoV2 entry protein ACE2 in the human nose and olfactory bulb. Cells Tissues Organs 2021; 209: 155-164.

[15] Khan M, Yoo S—J, Clijsters M, et al. Visualizing in deceased COVID—19 patients how SARS—CoV—2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb. Cell 2021; 184: 5932-5949.e15.

[16] Conde Cardona G, Quintana Pájaro LD, Quintero Marzola ID, et al. Neurotropism of SARS—CoV 2: mechanisms and manifestations. J Neurol Sci 2020; 412: 116824.

[17] Hoffmann M, Kleine—Weber H, Schroeder S, et al. SARS—CoV—2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020; 181: 271-280.e8.

[18] Glezer I, Malnic B. Olfactory receptor function. Handb Clin Neurol 2019; 164: 67-78.

[19] Aragão MFVV, Leal MC, Cartaxo Filho OQ, et al. Anosmia in COVID—19 associated with injury to the olfactory bulbs evident on MRI. AJNR Am J Neuroradiol 2020; 41: 1703-1706.

[20] Netland J, Meyerholz DK, Moore S, et al. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol 2008; 82: 7264-7275.

[21] McCray PB, Pewe L, Wohlford—Lenane C, et al. Lethal infection of K18—hACE2 mice infected with severe acute respiratory syndrome coronavirus. J Virol 2007; 81: 813-821.

[22] Laurendon T, Radulesco T, Mugnier J, et al. Bilateral transient olfactory bulb edema during COVID—19—related anosmia. Neurology 2020; 95: 224-225.

[23] Hura N, Xie DX, Choby GW, et al. Treatment of post—viral olfactory dysfunction: an evidence—based review with recommendations. Int Forum Allergy Rhinol 2020; 10: 1065-1086.

[24] Ojha P, Dixit A. Olfactory training for olfactory dysfunction in COVID‐19: a promising mitigation amidst looming neurocognitive sequelae of the pandemic. Clin Exp Pharmacol Physiol 2022; 49: 462-473.

[25] Seo BS, Lee HJ, Mo J—H, et al. Treatment of postviral olfactory loss with glucocorticoids, Ginkgo biloba, and mometasone nasal spray. Arch Otolaryngol Head Neck Surg 2009; 135: 1000-1004.

[26] Damm M, Pikart LK, Reimann H, et al. Olfactory training is helpful in postinfectious olfactory loss: a randomized, controlled, multicenter study: Olfactory Training. Laryngoscope 2014; 124: 826-831.

[27] Helman SN, Adler J, Jafari A, et al. Treatment strategies for postviral olfactory dysfunction: a systematic review. Allergy Asthma Proc 2022; 43: 96-105.

[28] Choi BY, Jeong H, Noh H, et al. Effects of olfactory training in patients with postinfectious olfactory dysfunction. Clin Exp Otorhinolaryngol 2021; 14: 88-92.

[29] O’Byrne L, Webster KE, MacKeith S, et al. Interventions for the treatment of persistent post—COVID—19 olfactory dysfunction. Cochrane Database Syst Rev 2022; 9: CD013876.

[30] Schepens EJA, Blijleven EE, Boek WM, et al. Correction: prednisolone does not improve olfactory function after COVID—19: a randomized, double—blind, placebo—controlled trial. BMC Med 2023; 21: 60.

[31] Wang K, Chen W, Zhou Y—S, et al. SARS—CoV—2 invades host cells via a novel route: CD147—spike protein . bioRxiv 2020.

[32] Vent J, Wang D, Damm M. Effects of traditional Chinese acupuncture in post‐viral olfactory dysfunction. Otolaryngol Head Neck Surg 2010; 142: 505-509.

[33] Dai Q, Pang Z, Yu H. Recovery of olfactory function in postviral olfactory dysfunction patients after acupuncture treatment. Evid Based Complement Alternat Med 2016; 2016: 4986034.

[34] Morita A, Murakami A, Uchihara T, et al. Case report: acupuncture is an effective treatment for olfactory dysfunction in the post COVID—19 condition. Front Neurol 2022; 13: 916944.

[35] Chen S, et al. Clinical features of Chinese medicine in patients with novel coronavirus pneumonia combined with olfactory disorders. J Liaoning Univ Tradit Chin Med 2021; 23: 52-56. Chinese

[36] Howick J, et al. The 2011 Oxford CEBM Levels of Evidence (Introductory Document). Oxford Centre for Evidence—Based Medicine. 2011. https://www.cebm.ox.ac.uk/resources/levels—of—evidence/ocebm—levels—of—evidence. Accessed August 25, 2025.

[37] Jiang RS, Liang KL. Establishment of olfactory diagnosis for the traditional Chinese version of the University of Pennsylvania Smell Identification Test. Int Forum Allergy Rhinol 2016; 6: 1308-1314.

[38] Lin Y. A case of olfactory disturbance treated by acupuncture in sequelae of sinusitis. Fujian J Tradit Chin Med 1963; 8(2): 41.

[39] Michael W. Anosmia treated with acupuncture. Acupunct Med 2003; 21: 153-154.

[40] Zhong D, Li Y, Zhong L. A case of hypoolfaction treated by TCM. Massage Guid 2008; 2: 40-41.

[41] Liu Z, Niu W, Yang X, et al. Clinical study on olfactory dysfunction of vascular dementia treated by three olfactory needles. New J Tradit Chin Med 2011; 43: 99-100.

[42] Wang X, Chen Y. A case of loss of smell after cold and flu treated by Chen Yuelai using the Wen Tong acupuncture method. J Chin Med Lit 2017; 35: 50-51.

[43] Hunter JE, Phillips ME, Walker FDL, et al. Post—viral olfactory dysfunction treated with acupuncture. Acupunct Med 2021; 39: 738-739.

[44] Bhat AK, Krishna Kumar V, Johnson JD. An integrative approach with Ayurveda and Traditional Chinese Acupuncture in post covid parosmia—a case study. J Ayurveda Integr Med 2022; 14(1): 100560.

[45] Ye S, Chen C. Medical case report of Chen Chao—Ming applying acupuncture combined with chiropractic for the treatment of traumatic olfactory disorder. Chin Folk Rem 2022; 30: 105-107.

[46] Li M, Ding Y, Ding M. A case report of treating anosmia after COVID—19 infection with Du’s Jin Needle “heat—reinforcing needling technique” combined with sphenopalatine ganglion acupuncture. Chin Folk Ther 2025; 33: 93-96.

[47] Wang C, et al. Two medical cases of acupuncture treatment for COVID—19 infection accompanied by olfactory dysfunction. J New Chin Med 2025; 57: 146-150.

[48] Zhu L, Zhao S, Zhang Z, et al. A proven case of acupuncture treatment for anosmia. J Pract Tradit Chin Med 2023; 39: 1889-1890.

[49] Wang P, et al. Fang Jianqiao’s experience in treating post—COVID olfactory dysfunction with combined acupuncture and medicine. Zhejiang J Tradit Chin Med 2024; 59: 999.

[50] Li K, Ding Y, Xia X, et al. Professor Sun Yuanzheng’s experience in acupuncture treatment of post—viral olfactory dysfunction. J Zhejiang Chin Med Univ 2022; 46: 1103-1106.

[51] Nan Y, et al. Liu Zhibin’s clinical experience in acupuncture treatment of olfactory dysfunction after upper respiratory tract infection. Lishizhen Med Mater Med Res 2025; 36: 1357-1361.

[52] Cheng D, Liang M, Zhou M, et al. Ma Ruijie’s experience in treating post—viral olfactory dysfunction with nasal three—needle combined with grain—sized moxibustion. Zhejiang J Tradit Chin Med 2024; 59: 799-801.

[53] Shen L. Twelve cases of anosmia were treated by acupuncture combined with acupoint injection. New J Tradit Chin Med 2001; 33(4): 44.

[54] Liu Q, Liu J. Treatment of anosmia by internal Yingxiang acupuncture. J Beijing Univ Tradit Chin Med (Clin Med) 2011; 18: 21-22.

[55] Niu W, Liu Z, Yang X, et al. 100 cases of olfactory dysfunction were treated by three acupuncture. Shanxi J Tradit Chin Med 2008;(08): 1054-1055.

[56] Niu W, Liu Z, Yang X, et al. Clinical study on the improvement of olfactory function in patients with Alzheimer’s disease by sniffing three needles. Mod Chin Med 2009; 29(01): 45-46.

[57] Li Y. Treatment of 21 cases of nose disorders by Shugan Jieyu method. New Chin Med 2002;(09): 63-64.

[58] Jiang T, Yang Q, Li F. Tongtiao acupuncture—moxibustion method for 28 cases of long COVID—19 olfactory dysfunction. Chin Acupunct 2025; 45: 331-334.

[59] Pang Z, Yu H, Dai Q. Clinical study of acupuncture and acupoint injection for the treatment of olfactory disorder after viral infection. Chin J Integr Tradit West Med Otolaryngol 2016; 24: 23-26.

[60] Ma X, Feng H. Clinical study of acupuncture combined with acupoint injection for the treatment of olfactory disorder after viral infection. J Mod Integr Tradit Chin West Med 2020; 29: 3492-3495.

[61] Zheng M, Chen K, Huang J, et al. A clinical study on the effect of re—sniffing and enlightening acupuncture on the cognitive function and olfactory function of MCI patients. Asia—Pac Tradit Med 2021; 17: 76-79.

[62] Drews T, Hummel T, Rochlitzer B, et al. Acupuncture is associated with a positive effect on odour discrimination in patients with postinfectious smell loss—a controlled prospective study. Eur Arch Otorhinolaryngol 2022; 279: 1329-1334.

[63] Ding X, Zheng L, Bai S. Clinical efficacy of intranasal acupuncture in treating post—viral olfactory dysfunction and its effect on Toll—like receptor 3 expression and inflammatory immune response. Chin Arch Tradit Chin Med 2023; 41: 227-230.

[64] Mohebbi A, Bagheri SH, Raziabadi E, et al. Effects of frequency—controlled ear acupuncture on COVID—19—related refractory olfactory dysfunction: a randomized clinical trial. J Acupunct Meridian Stud 2024; 17: 69-75.

[65] Armstrong MF, O'Byrne TJ, Calva JJ, et al. The feasibility of investigating acupuncture in patients with COVID—19 related olfactory dysfunction. Glob Adv Integr Med Health 2025; 14: 27536130251343834.

[66] Subspecialty Group of Rhinology, Society of Otorhinolaryngology Head and Neck Surgery, Chinese Medical Association. Expert consensus on diagnosis and treatment of olfactory dysfunction. Chin J Otorhinolaryngol Head Neck Surg 2018; 53: 484-494.

[67] Subspecialty Group of Rhinology, C.M.A. Expert consensus on diagnosis and treatment of olfactory dysfunction (2017). Chin J Otorhinolaryngol Head Neck Surg 2018; 53: 484-494.

[68] Pieniak M, Oleszkiewicz A, Avaro V, et al. Olfactory training—thirteen years of research reviewed. Neurosci Biobehav Rev 2022; 141: 104853.

[69] Reden J, Mueller A, Mueller C, et al. Recovery of olfactory function following closed head injury or infections of the upper respiratory tract. Arch Otolaryngol—Head Neck Surg 2006; 132: 265-269.

[70] Hendriks AP. Olfactory dysfunction. Rhinology 1988; 26: 229-251.

[71] Heilmann S, Just T, Göktas O, et al. Effects of systemic or topical administration of corticosteroids and vitamin B in patients with olfactory loss. Laryngorhinootologie 2004; 83: 729-734.

[72] Hummel T, Barz S, Pauli E, et al. Chemosensory event—related potentials change with age. Electroencephalogr Clin Neurophysiol 1998; 108: 208-217.

[73] Mori T, et al. Clinical study of olfactory disturbance. Acta Otolaryngol 1998; 118: 197-201.

[74] Anzinger A, Albrecht J, Kopietz R, et al. Effects of laserneedle acupuncture on olfactory sensitivity of healthy human subjects: a placebo—controlled, double—blinded, randomized trial. Rhinology 2009; 47: 153-159.

[75] Vent J, Wang D—W, Damm M. Effects of traditional Chinese acupuncture in post—viral olfactory dysfunction. Otolaryngol Head Neck Surg 2010; 142: 505-509.